Work

Abstract C027: Persistent activation of this tumor-driving EGFR/RAS/RAF/MEK/MAPK/SIAH Pathway is highly prognostic in patient risk stratification, cancer disparity detection, and resistant/relapse/survival prediction at the 1st-line neoadjuvant settings

Year: 2023

Type: conference-abstract

Source: Cancer Epidemiology Biomarkers & Prevention

DOI: 10.1158/1538-7755.disp23-c027

Authors: Amy H. Tang, Richard A. Hoefer, Mary L. Guye, Billur Samli, Janet S. Winston, Jennifer Koblinski, Valentina Robila, Michael O. Idowu, Rick J. Jansen, Harry D. Bear

Institutions: Eastern Virginia Medical School, Sentara CarePlex Hospital, Sentara Norfolk General Hospital, Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University Medical Center, Masonic Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4389228068

Cites:

Cited by:

Related to: 10